DHFR2
Basic information
Region (hg38): 3:94047836-94063389
Previous symbols: [ "DHFRP4", "DHFRL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Joubert syndrome 8 (63 variants)
- not provided (9 variants)
- not specified (5 variants)
- Inborn genetic diseases (5 variants)
- Joubert syndrome and related disorders (1 variants)
- Familial aplasia of the vermis (1 variants)
- Joubert syndrome 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DHFR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 33 | 34 | 70 | |||
Total | 0 | 1 | 33 | 34 | 2 |
Variants in DHFR2
This is a list of pathogenic ClinVar variants found in the DHFR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-94049358-G-A | not specified | Benign/Likely benign (Mar 01, 2019) | ||
3-94049386-T-C | Joubert syndrome 8 | Likely benign (Jul 17, 2023) | ||
3-94049389-T-C | not specified | Likely benign (Jul 10, 2017) | ||
3-94049403-T-A | Joubert syndrome 8 | Uncertain significance (Feb 04, 2022) | ||
3-94049410-T-C | Joubert syndrome 8 | Likely benign (May 01, 2023) | ||
3-94049413-T-C | Joubert syndrome 8 | Benign/Likely benign (Aug 23, 2023) | ||
3-94049414-A-G | Joubert syndrome 8 | Uncertain significance (Apr 20, 2021) | ||
3-94049424-C-G | not specified • Joubert syndrome 8 | Benign (Jan 31, 2024) | ||
3-94049426-A-G | Joubert syndrome 8 • ARL13B-related disorder | Likely benign (Jan 26, 2024) | ||
3-94049431-A-G | Joubert syndrome 8 | Likely benign (Aug 31, 2022) | ||
3-94049439-T-C | Joubert syndrome 8 | Uncertain significance (Oct 04, 2022) | ||
3-94049448-A-G | Joubert syndrome 8 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 23, 2022) | ||
3-94049450-C-T | Joubert syndrome 8 | Uncertain significance (Aug 20, 2020) | ||
3-94049451-A-G | Joubert syndrome 8 • Inborn genetic diseases | Uncertain significance (Sep 01, 2022) | ||
3-94049452-C-G | Joubert syndrome 8 | Uncertain significance (Jul 23, 2022) | ||
3-94049454-G-A | Joubert syndrome 8 | Uncertain significance (Jan 03, 2020) | ||
3-94049470-T-C | Joubert syndrome 8 | Likely benign (Aug 04, 2021) | ||
3-94049471-A-G | Joubert syndrome 8 | Uncertain significance (Nov 01, 2022) | ||
3-94049475-A-G | Joubert syndrome 8 | Uncertain significance (Jun 06, 2021) | ||
3-94049498-A-T | Joubert syndrome 8 | Uncertain significance (Jul 19, 2022) | ||
3-94049499-C-T | Joubert syndrome 8 • Inborn genetic diseases | Uncertain significance (Jul 15, 2022) | ||
3-94049500-G-A | Joubert syndrome 8 | Likely benign (Oct 05, 2023) | ||
3-94049503-A-C | Likely benign (Aug 01, 2024) | |||
3-94049506-C-T | Joubert syndrome 8 | Likely benign (Sep 20, 2023) | ||
3-94049513-C-G | Joubert syndrome 8 | Uncertain significance (Apr 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DHFR2 | protein_coding | protein_coding | ENST00000394221 | 1 | 15554 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.225 | 0.657 | 125603 | 0 | 4 | 125607 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.597 | 81 | 97.6 | 0.830 | 0.00000504 | 1243 |
Missense in Polyphen | 30 | 31.131 | 0.96368 | 420 | ||
Synonymous | -0.830 | 42 | 35.7 | 1.18 | 0.00000208 | 336 |
Loss of Function | 1.10 | 1 | 3.10 | 0.323 | 2.00e-7 | 38 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000882 | 0.00000880 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Binds its own mRNA and that of DHFR. {ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:21876188}.;
- Pathway
- Folate biosynthesis - Homo sapiens (human);One carbon pool by folate - Homo sapiens (human);Trans-sulfuration and one carbon metabolism;One carbon metabolism and related pathways;Metabolism;Metabolism of folate and pterines;dTMP <i>de novo</i> biosynthesis (mitochondrial);Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.19
- rvis_percentile_EVS
- 66.82
Haploinsufficiency Scores
- pHI
- 0.445
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene ontology
- Biological process
- one-carbon metabolic process;thymidine biosynthetic process;dihydrofolate metabolic process;tetrahydrofolate metabolic process;tetrahydrofolate biosynthetic process;folic acid metabolic process;oxidation-reduction process
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial matrix
- Molecular function
- mRNA binding;dihydrofolate reductase activity;NADP binding